1. Michael Bonn,Urte Eydeler,Martin Barkworth,Lucio C. Rovati (2009). Bioequivalence Study of Generic Tablet Formulations Containing Ethinylestradiol and Chlormadinone Acetate in Healthy Female Volunteers. Arzneimittelforschung, 59(12), 651-658.
2. B William (2006). Effects of a New Hormone Therapy, Drospirenone and 17-ß-Estradiol, in Postmenopausal Hypertension. Hypertension, 48, 246-253.
3. A Karara (2006). Pharmacokinetics and Pharmacodynamics of Drospirenone-Estradiol Combination. Hormone Therapy Product Forecast, 31, 446-479.
4. W Sitruk (1995). Pharmacology of oral contraceptives. Rev. Prat, 45, 2401-2406.
5. H Innhoffen (1938). Neue per os-wirksame weibliche Keimdrüsenhormon-Derivate: 17-Äthinylöstradiol und Pregnene-in-on-3-ol-17. Naturwissenschaften, 26, 96-479.
6. Susan Keam,Antona Wagstaff (2003). Ethinylestradiol/Drospirenone. Treatments in Endocrinology, 2(1), 49-70.
7. J Sartoretto (1977). Clinical studies with a low dose estrogen-progestogen combination. Contraception, 15, 563-570.
8. D Back,A Breckenridge,M Maciver,M Orme,H Purba,P Rowe,I Taylor (1982). The gut wall metabolism of ethinyloestradiol and its contribution to the pre‐systemic metabolism of ethinyloestradiol in humans. British Journal of Clinical Pharmacology, 13(3), 325-330.
9. S Rogers,D Back,P Stevenson,S Grimmer,M Orme (1987). Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol. British Journal of Clinical Pharmacology, 23(6), 721-725.
10. F Guengerich (1990). Metabolism of 17 alphaethynylestradiol in humans. Life Sci, 47, 1981-1988.
11. M Williams,E Helton,J Goldzieher (1975). The urinary metabolites of 17α-ethynylestradiol-9α,11-3H in women chromatographic profiling and identification of ethynyl and non-ethynyl compounds. Steroids, 25(2), 229-246.
12. W Oelkers (1991). Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women. J Clin Endocrinol Metab, 73, 837-842.
13. Peter Muhn,Rolf Krattenmacher,Sybille Beier,Walter Elger,Ekkehard Schillinger (1995). Drospirenone: A novel progestogen with antimineralocorticoid and antiandrogenic activity. Contraception, 51(2), 99-110.
14. Peter Muhn,Ulrike Fuhrmann,Karl Fritzemeier,Rolf Krattenmacher,Ekkehard Schillinger (1995). Drospirenone: a Novel Progestogen with Antimineralocorticoid and Antiandrogenic Activity. Annals of the New York Academy of Sciences, 761(1), 311-335.
15. W Oelkers (2004). Drospirenone, a progestogen with antimineralocorticoid properties: a short review. Mol. Cell. Endocrinol, 217, 255-261.
16. A Rapkin (2007). Drospirenone: a novel progestin. Expert Opin. Pharmacother, 8, 989-999.
17. H Blode (2000). A 1-year pharmacokinetic investigation of a novel oral contraceptive containing drospirenone in healthy female volunteers. Eur. J. Contracept. Reprod. Health Care, 5, 256-264.
18. (2007). Pharmacokinetics and Statistical analysis The first-order terminal elimination rate constant (Ke) was estimated by linear regression from the points Coadministered With Hydrochlorothiazide in Hypertensive Postmenopausal Women. J. Clin. Pharmacol, 47, 1292-1302.
19. N Ezell (2000). Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception, 62, 29-38.
20. Rolf Schürmann,Hartmut Blode,Norbert Benda,Maureen Cronin,Andreas Küfner (2006). Effect of Drospirenone on Serum Potassium and Drospirenone Pharmacokinetics in Women With Normal or Impaired Renal Function. The Journal of Clinical Pharmacology, 46(8), 867-875.
21. K Parsey (2000). An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception, 61, 105-111.
22. J Huber (2000). Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone. Eur. J. Contracept. Reprod. Health Care, 5, 25-34.
23. D Foster (2006). Number of oral contraceptive pill packages dispensed, method continuation, and costs. Obstet. Gynecol, 108, 1107-1114.
24. J Smith (2005). Why do women miss oral contraceptive pills? An analysis of women's selfdescribed reasons for missed pills. J. Midwifery Womens Health, 50, 380-385.
25. B Laurie (2010). Benefits of Hormonal Contraception May Extend Beyond Pregnancy Prevention. Obstet. Gynecol, 115, 206-218.
26. D Archer (2005). Long-term safety of drospirenoneestradiol for hormone therapy: A randomized, double-blind, multicenter trial. Menopause, 12, 716-727.
27. Odisseas Gregoriou,Kostantinos Papadias,Sokratis Konidaris,Kostantina Bakalianou,Nikolaos Salakos,Nikolaos Vrachnis,George Creatsas (2008). Treatment of hirsutism with combined pill containing drospirenone. Gynecological Endocrinology, 24(4), 220-223.
28. William Koltun,Anne Lucky,Diane Thiboutot,Minoo Niknian,Carole Sampson-Landers,Paul Korner,Joachim Marr (2008). Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial. Contraception, 77(4), 249-256.
29. D Back,A Breckenridge,Francesca Crawford,M Maciver,M Orme,P Rowe,Margaret Watts (1979). An investigation of the pharmacokinetics of ethynylestsadiol in women using badioimmunoassay. Contraception, 20(3), 263-273.
30. S Saperstein (1989). Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol. Contraception, 40(5), 581-590.
31. A Rebecca (2003). The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy. J. Clin. Pharmacol, 43, 52-58.
32. M Díaz‐cruz,María López De Alda,Ramón López,Damià Barceló (2003). Determination of estrogens and progestogens by mass spectrometric techniques (GC/MS, LC/MS and LC/MS/MS). Journal of Mass Spectrometry, 38(9), 917-923.
33. D Matejicek (2007). High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel. Anal. Chim. Acta, 588, 304-315.
34. B Christiaens,M Fillet,P Chiap,O Rbeida,A Ceccato,B Streel,J Graeve,J Crommen,P Hubert (2004). Fully automated method for the liquid chromatographic–tandem mass spectrometric determination of cyproterone acetate in human plasma using restricted access material for on-line sample clean-up. Journal of Chromatography A, 1056(1-2), 105-110.
35. Tomohiko Isobe,Hiroaki Shiraishi,Masaru Yasuda,Akiko Shinoda,Hiroshi Suzuki,Masatoshi Morita (2003). Determination of estrogens and their conjugates in water using solid-phase extraction followed by liquid chromatography–tandem mass spectrometry. Journal of Chromatography A, 984(2), 195-202.
36. L Hermes (2007). A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry. Journal of chromatography B, 852, 69-76.
37. Sharanya Reddy,Charles Iden,Bruce Brownawell (2005). Analysis of Steroid Conjugates in Sewage Influent and Effluent by Liquid Chromatography−Tandem Mass Spectrometry. Analytical Chemistry, 77(21), 7032-7038.
38. N Twaddle (2003). Analysis of steroid estrogen conjugates in municipal waste waters by liquid chromatography-tandem mass spectrometry. Journal of chromatography B, 793, 309-315.
39. S Zuehlke (2005). Determination of estrogenic steroids in surface and wastewater applying liquid chromatography-electrospray tandem mass spectrometry. Journal of separation science, 28, 52-58.
40. Uttam Bhaumik,Animesh Ghosh,Uttam Mandal,Bappaditya Chatterjee,Amlan Sarkar,Anirbandeep Bose,Kamala Ray,Tapan Pal (2008). Determination of Drospirenone in Human Plasma by LC–Tandem-MS. Chromatographia, 68(9-10), 713-720.
41. N Borges (2009). A novel and sensitive method for ethinylestradiol quantification in human plasma by high-performance liquid chromatography coupled to atmospheric pressure photoionization (APPI) tandem mass spectrometry: Application to a comparative pharmacokinetics study. Journal of Chromatography B, 877, 3601-3609.
42. Roger Giese (2003). Measurement of endogenous estrogens: analytical challenges and recent advances. Journal of Chromatography A, 1000(1-2), 401-412.
43. K Zhang (2007). Microwave -accelerated derivatization for the simultaneous gas chromatography -mass spectrometric analysis of natural and synthetic estrogenic steroid hormones. Journal of chromatography A, 1148, 211-218.
